Lexaria Bioscience (QX) Stock Price

0.00285 (1.47%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexaria Bioscience Corporation (QX) LXRP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00285 1.47% 0.19715 16:31:25
Open Price Low Price High Price Close Price Previous Close
0.21 0.1943 0.22 0.19715 0.1943
Bid Price Ask Price Spread News
0.1943 0.227 0.0327 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
66 109,007 $ 0.199828 $ 21,783 230,748 0.17 - 0.57
Last Trade Time Type Quantity Stock Price Currency
15:57:10 30 $ 0.19715 USD

Lexaria Bioscience (QX) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 17.75M 90.04M 62.05M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.73k $ - 0.00% - -

more financials information »

Lexaria Bioscience (QX) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.205250.240.1910.2037285322,654-0.0081-3.95%
1 Month0.,2080.0271515.97%
3 Months0.3050.33950.170.2316829242,945-0.10785-35.36%
6 Months0.340.52120.170.2611041163,192-0.14285-42.01%
1 Year0.44330.570.170.2990143135,617-0.24615-55.53%
3 Years0.7852.540.171.19182,022-0.58785-74.89%
5 Years0.21522.540.080.9138565171,271-0.01805-8.39%

Lexaria Bioscience (QX) Description

Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October. 2016. Lexaria's technology provides increases of up to 1Ox in intestinal absorption rates; more rapid delivery to the bloodstream with effects often with in 15-20 minutes; and important taste-masking benefits for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.